Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr:304:106084.
doi: 10.1016/j.tvjl.2024.106084. Epub 2024 Feb 29.

Malassezia dermatitis in dogs and cats

Affiliations
Review

Malassezia dermatitis in dogs and cats

Stefan Hobi et al. Vet J. 2024 Apr.

Abstract

Malassezia are members of the mycobiome of dogs and cats. In the presence of an underlying disease, these yeasts can proliferate, attach to the skin or mucosa to induce a secondary Malassezia dermatitis, otitis externa or paronychia. Since allergic dermatitis is one of the most common underlying causes, diagnostic investigation for allergy is often indicated. Cats may suffer from various other underlying problems, especially where Malassezia dermatitis is generalised. Malassezia dermatitis in dogs and cats is chronic, relapsing and pruritic. Direct cytology from dermatological lesions and the ear canal, showing "peanut-shaped" budding yeasts, facilitates a rapid and reliable diagnosis. Topical treatment includes antiseptic and antifungal azole-based products. Systemic treatment with oral antifungals is indicated only in severe or refractory disease. Identification and treatment of the underlying cause is essential for an optimal response. In this evidence-based narrative review, we discuss the clinical presentation of Malassezia dermatitis in dogs and cats, underlying comorbidities, and diagnostic considerations. Treatment is discussed in light of emerging evidence of antifungal resistance and the authors' clinical experience.

Keywords: Azoles; Dermatology; Malassezia; Small animals; Treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Ralf Mueller has been a consultant, lectured for or received support for research from the following companies manufacturing or selling antifungal medications: Ceva (topical chlorhexidine), Elanco (Malaseb shampoo, itraconazole), Selectavet (enilconazole) and Virbac (topical chlorhexidine). None of the other authors of this paper has a financial or personal relationship with other people or organizations that could inappropriately influence or bias the content of the paper.

Substances

LinkOut - more resources